Literature DB >> 17638073

The organization and financing of dialysis and kidney transplantation services in New Zealand.

Toni Ashton1, Mark Roger Marshall.   

Abstract

In New Zealand, patients receive treatment for end-stage renal disease (ESRD) within the tax-funded health system. All hospital and specialist outpatient services are free, while general practitioner consultations and pharmaceuticals prescribed outside of hospitals incur copayments. Total ESRD prevalence is 0.07%, half the U.S. rate, and the prevalence of home-based and self-care dialysis is the highest in the world. Medical staff are not subject to direct financial incentives that could affect treatment choice. Estimated total expenditure per ESRD patient is relatively low. Funding constraints encourage physicians and patients to consider the probable benefit of dialysis for a patient before treatment is prescribed.

Entities:  

Mesh：

Year:  2007        PMID： 17638073     DOI： 10.1007/s10754-007-9023-x

Source DB:  PubMed          Journal:  Int J Health Care Finance Econ        ISSN： 1389-6563


  24 in total

1.  Access to renal dialysis in South Auckland.

Authors:  Sandra Coney
Journal:  Lancet       Date:  1994-09-03       Impact factor: 79.321

2.  Gifts of life in short supply.

Authors:  Justin Roake
Journal:  N Z Med J       Date:  2002-08-09

3.  Dialysis in the elderly.

Authors:  Justin Roake
Journal:  N Z Med J       Date:  2004-06-04

Review 4.  High-technology medicine and the old: the dialysis example.

Authors:  C M Kjellstrand
Journal:  J Intern Med       Date:  1996-03       Impact factor: 8.989

5.  Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis.

Authors:  E F Vonesh; J Moran
Journal:  J Am Soc Nephrol       Date:  1999-02       Impact factor: 10.121

6.  Primary care and health system performance: adults' experiences in five countries.

Authors:  Cathy Schoen; Robin Osborn; Phuong Trang Huynh; Michelle Doty; Karen Davis; Kinga Zapert; Jordon Peugh
Journal:  Health Aff (Millwood)       Date:  2004 Jul-Dec       Impact factor: 6.301

7.  Access to dialysis in New Zealand renal services.

Authors:  John Collins; Patricia Metcalf
Journal:  N Z Med J       Date:  2003-06-06

Review 8.  Systematic review of the effectiveness of home versus hospital or satellite unit hemodialysis for people with end-stage renal failure.

Authors:  Graham Mowatt; Luke Vale; Alison MacLeod
Journal:  Int J Technol Assess Health Care       Date:  2004       Impact factor: 2.188

9.  Current incidence, treatment patterns and outcome of end-stage renal disease among indigenous groups in Australia and New Zealand.

Authors:  Stephen P McDonald; Graemer R Russ
Journal:  Nephrology (Carlton)       Date:  2003-02       Impact factor: 2.506

10.  Late referral to a nephrologist reduces access to renal transplantation.

Authors:  Alan Cass; Joan Cunningham; Paul Snelling; John Z Ayanian
Journal:  Am J Kidney Dis       Date:  2003-11       Impact factor: 8.860
View more
  16 in total

Review 1.  End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

Authors:  Avi Dor; Mark V Pauly; Margaret A Eichleay; Philip J Held
Journal:  Int J Health Care Finance Econ       Date:  2007-09

2.  International Study of Health Care Organization and Financing of renal services in England and Wales.

Authors:  Tricia Nicholson; Paul Roderick
Journal:  Int J Health Care Finance Econ       Date:  2007-12

3.  International study of health care organization and financing: development of renal replacement therapy in Germany.

Authors:  Werner Kleophas; Helmut Reichel
Journal:  Int J Health Care Finance Econ       Date:  2007-09

4.  A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events.

Authors:  Anne-Line Couillerot-Peyrondet; Cléa Sambuc; Yoël Sainsaulieu; Cécile Couchoud; Isabelle Bongiovanni-Delarozière
Journal:  Eur J Health Econ       Date:  2016-05-05

5.  The financing and organization of medical care for patients with end-stage renal disease in Sweden.

Authors:  Björn Wikström; Michael Fored; Margaret A Eichleay; Stefan H Jacobson
Journal:  Int J Health Care Finance Econ       Date:  2007-12

Review 6.  International Study of Health Care Organization and Financing for end-stage renal disease in France.

Authors:  Isabelle Durand-Zaleski; Christian Combe; Philippe Lang
Journal:  Int J Health Care Finance Econ       Date:  2007-09

Review 7.  Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease.

Authors:  Wim Van Biesen; Norbert Lameire; Patrick Peeters; Raymond Vanholder
Journal:  Int J Health Care Finance Econ       Date:  2007-09

8.  Patient and caregiver preferences for home dialysis-the home first study: a protocol for qualitative interviews and discrete choice experiments.

Authors:  Rachael C Walker; Rachael L Morton; Allison Tong; Mark R Marshall; Suetonia Palmer; Kirsten Howard
Journal:  BMJ Open       Date:  2015-04-15       Impact factor: 2.692

9.  Exsanguination of a home hemodialysis patient as a result of misconnected blood-lines during the wash back procedure: a case report.

Authors:  Kerryanne Allcock; Balaji Jagannathan; Christopher J Hood; Mark R Marshall
Journal:  BMC Nephrol       Date:  2012-05-15       Impact factor: 2.388

Review 10.  A Global Overview of the Impact of Peritoneal Dialysis First or Favored Policies: An Opinion.

Authors:  Frank Xiaoqing Liu; Xin Gao; Gary Inglese; Piyatida Chuengsaman; Roberto Pecoits-Filho; Alex Yu
Journal:  Perit Dial Int       Date:  2014-07-31       Impact factor: 1.756
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.